A Study of Xiangjurupining Capsule in the Treatment of Hyperplasia of Breast (Liver Stagnation and Phlegm Coagulation)
Clinical trial NCT04229706 · COMPLETED
Trial details
- NCT number
- NCT04229706
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-31
- Primary completion
- 2022-01-12
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.